Mazdutide
Clinical Study of IBI362 in Healthy Chinese Male Subjects
Innovent · Phase 1 · Completed · Enrollment 24
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| IBI362 liquid formulation | n/r | n/r | n/r | n/r |
| IBI362 lyophilized powder | n/r | n/r | n/r | n/r |
Not shown
- IBI362 liquid formulation: endpoint not reported
- IBI362 lyophilized powder: endpoint not reported